Not long ago, a team of neuroscientists and surgeons in Israel reported something that sounds like science fiction. A man in active opioid withdrawal underwent
EMDR targets the traumatic memories that often underlie substance use, using bilateral stimulation to reduce their emotional charge and intensity. Here is what the clinical research shows about how it works, who benefits, and what to expect from the process.
Fame and Fentanyl explores how Prince, Tom Petty, Mac Miller, and others died not from addiction, but from unknowing exposure to a laced drug supply.
Stress is one of the most powerful relapse triggers in recovery. Here is how the brain’s stress circuits hijack motivation, why relapse becomes relief-seeking, and what lowers the risk.
NAD+ therapy aims to restore the cellular energy and repair systems that addiction depletes. Here is how it is used in detox and recovery, what the evidence shows, and why it works best as an adjunct.
An evidence-based look at what early research does, and does not, suggest about GLP-1 therapy such as semaglutide for methamphetamine use disorder.
An evidence-based look at what current research does, and does not, show about GLP-1 medications such as semaglutide for cocaine use disorder.
Somatic Experiencing treats trauma and addiction through the body, calming a dysregulated nervous system so cravings and triggers lose their grip. Here is how it works and where it fits.
EMDR therapy helps people with co-occurring trauma and addiction by reprocessing the memories that drive cravings, lowering the emotional charge behind triggers and reducing relapse risk.
Addiction is not a failure of willpower. Learn how repeated substance use rewires the brain’s reward, habit, and control circuits, and how treatment uses that same plasticity to rebuild control.
Why GLP-1 Alone Is Not Enough for Addiction Recovery Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment Is a GLP-1
How GLP-1 Drugs Affect Dopamine and Reward Pathways Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment How do GLP-1 receptor
The Future of GLP-1 Medications in Addiction Medicine Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment What is the future
GLP-1 and Nicotine Addiction: Can Semaglutide Help You Quit? Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment Can GLP-1 receptor
Can GLP-1 Medications Help Reduce Opioid Cravings? Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment Can GLP-1 medications help reduce
Managing Nausea and GLP-1 Side Effects in Recovery Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment How do you manage
GLP-1 Agonists and Stimulant Addiction: What We Know Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment Can GLP-1 medications help
Semaglutide for Alcohol Use Disorder: What Research Shows Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment Can semaglutide treat alcohol
Tirzepatide vs. Semaglutide for Substance Cravings Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment Which medication is more effective for
Alcohol use disorder in veterans shows as a cluster of behavioral, physical, and psychological signs shaped by military experience, trauma, and reintegration stress. Recognizing the patterns early, understanding how PTSD and co-occurring conditions complicate the picture, and knowing which treatment models work best for veterans can shorten the path from concern to effective care.
Sometimes talking over the phone is easier. We’re here to listen to your questions and help you get answers. Call us at:
